What is the future for CSF biomarkers in the prediction of cognitive decline and Alzheimer''s disease?

Authors: Blennow, Kaj; Zetterberg, Henrik

Source: Aging Health, Volume 4, Number 3, June 2008 , pp. 213-215(3)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Document Type: Editorial

DOI: http://dx.doi.org/10.2217/1745509X.4.3.213

Affiliations: 1: 1The Sahlgrenska Academy at Gööteborg University, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, SE-431 80 Möölndal, Sweden., Email: kaj.blennow@neuro.gu.se

Publication date: 2008-06-01

More about this publication?

Aging Health leading coverage of current and emerging topics relating to the safe and effective management of therapy in the elderly, all subject to rigorous peer review. The journal focuses on the most important advances and highlights their relevance in the clinical setting. The journal has been designed to deliver essential concise information in an easily assimilable format - vital for the increasingly time-constrained professional.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites